Skip to content

Naloxone Distribution

The Office of Drug Policy (ODP) is pleased to announce the release of its FY19 First Responder Naloxone Mini-Grant Program.  The purpose of the program is to reduce the incidence of morbidity and mortality related to opioid overdoses in communities in Idaho through the purchase and placement of naloxone, an opioid antagonist used to rapidly reverse the effects of opioid overdoses.

On July 1, 2015, Idaho's law allowing easier access to naloxone went into effect. Since that time, significant progress has been made in educating prescribers and pharmacists about the new law and their roles in it. Many pharmacies are now stocking naloxone and prescribers and pharmacists are becoming more knowledgeable and comfortable recommending and dispensing the medication. The next step is getting this life-saving drug into the hands of those who are in a position to assist a person at risk of experiencing an opioid-related overdose, including first responders. When equipped, first responders will be able to administer naloxone and keep an overdose patient alive until they can be transported to an emergency department.

ODP has received grant funding for the purchase and distribution of naloxone kits to all first responders and agencies who are awarded ODP First Responder Naloxone Grants.

ODP has 100 kits (each kit contains 2 doses) of 4mg Naloxone Nasal Spray available through this grant. Because supplies are limited, we encourage agencies to submit a request form by February 15, 2019. Agencies that receive naloxone through this mini-grant program will be asked to provide brief, online, quarterly reports.

For more information, contact Shaina Cales at or (208) 854-3042.

ver: 2.1.0 | last updated: